GSK extends presence in Asia with new strategic alliance in South Korea
- Details
- Category: GlaxoSmithKline

Merck Positioned to Drive Growth Through Innovative Portfolio, Pipeline and Strategy
- Details
- Category: Merck

Abbott licenses 24 Zydus pharmaceutical products for 15 high-growth emerging markets
- Details
- Category: Abbott

GSK Statement on FDA Advisory Committee meeting on Rotavirus vaccines
- Details
- Category: GlaxoSmithKline

EDUCARE (EDUcation for Cancer in African REgions) Project
- Details
- Category: Roche

Bayer Schering Pharma Initiates Phase III Trial of Regorafenib
- Details
- Category: Bayer

Bayer Schering Pharma Initiates Phase III Trial of Regorafenib (BAY 73-4506)
- Details
- Category: Bayer

More Pharma News ...
- Lundbeck delivers strong growth
- Boehringer Ingelheim and Micromet announce global collaboration for multiple myeloma BiTE antibody
- Bayer Schering Pharma and EndoCeutics Enter into a Global Agreement
- Merck Announces First-Quarter 2010 Financial Results
- FDA approved VIMOVO for arthritis patients at risk of developing NSAID-associated gastric ulcers
- Nycomed and Merck & Co., Inc., announce commercialization agreements for Daxas®
- Bristol-Myers Squibb Reports Strong Sales, Earnings Performance in First Quarter